Paradoxical use of an alpha adrenoceptor agonist (methoxamine) an an antihypertensive
Saran, R.K.; Ahuja, R.C.; Gupta, N.N.
Journal of the Association of Physicians of India 28(1-2): 39-43
1980
ISSN/ISBN: 0004-5772 PMID: 7216966 Document Number: 167870
Document emailed within 1 workday
Related Documents
Piascik, M.T.; Butler, B.T.; Pruitt, T.A.; Kusiak, J.W. 1990: Agonist interaction with alkylation-sensitive and -resistant alpha-1 adrenoceptor subtypes Journal of Pharmacology and Experimental Therapeutics 254(3): 982-991Gesek, F.A.; Strandhoy, J.W. 1989: Alpha adrenoceptor agonist stimulation of oxygen consumption in rat proximal and distal nephrons Journal of Pharmacology and Experimental Therapeutics 249(2): 529-534
Brooks, D.P.; Edwards, R.M.; Depalma, P.D.; Fredrickson, T.A.; Hieble, J.P.; Gellai, M. 1991: The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependent Journal of Pharmacology and Experimental Therapeutics 259(3): 1277-1282
Campanacci, L.; Bellini, G.; Battilana, G.; Rigoni, A.; Cosenzi, A.; Carretta, R.; Puppis, E.; Pierini, B.; Faccini, L. 1984: Central alpha-adrenergic agonist antihypertensive drugs and renal failure La Clinica Terapeutica 109(4): 301-309
DiBona, G.F. 1984: Central nervous system-renal interrelationship in mechanism of action of guanabenz: role of peripheral alpha 2-adrenoceptor agonist activity Journal of Cardiovascular Pharmacology 6(Suppl 3): S543-S544
Lindgren, B.R.; Grundström, N.; Andersson, R.G. 1988: Effects of an alpha-2 adrenoceptor agonist on angiotensin converting enzyme inhibitor-induced hypotension and potentiated allergen-evoked inflammatory skin responses Journal of Pharmacology and Experimental Therapeutics 245(3): 932-935
Martin, D.J.; Lluel, P.; Guillot, E.; Coste, A.; Jammes, D.; Angel, I. 1997: Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists Journal of Pharmacology and Experimental Therapeutics 282(1): 228-235
Xiao, X.H.; Rand, M.J. 1990: Vasoconstrictor responses to the alpha 2-adrenoceptor agonist UK14304 during responses to noradrenaline, phenylephrine, serotonin and vasopressin of the rat tail artery Archives Internationales de Pharmacodynamie et de Therapie 308: 63-75
Kazanietz, M.G.; Enero, M.A. 1990: Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol Journal of Pharmacology and Experimental Therapeutics 252(2): 758-764
Weetman, D.F.; Jahn, U.; Ismail, S.; Chadwick, M.A.; Coates, J.; Lawson, K.; Turner, N.; Thiele, K. 1983: Sgd 101/75: a sympathomimetic that can be used to identify a new subtype of alpha-adrenoceptor, the alpha 1s-adrenoceptor Methods and Findings in Experimental and Clinical Pharmacology 5(7): 425-434
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Luo, X-J.; Zheng, M.; Tian, G.; Zhong, H-Y.; Zou, X-J.; Jian, D-L. 2016: Comparison of the treatment effects of methoxamine and combining methoxamine with atropine infusion to maintain blood pressure during spinal anesthesia for cesarean delivery: a double blind randomized trial European Review for Medical and Pharmacological Sciences 20(3): 561-567
Oriowo, M.A.; Chapman, H.; Kirkham, D.M.; Sennitt, M.V.; Ruffolo, R.R.; Cawthorne, M.A. 1996: The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344 Journal of Pharmacology and Experimental Therapeutics 277(1): 22-27
Sørensen, E.V. 1993: Xamoterol--a beta-1-adrenoceptor partial agonist. Pharmacology and clinical use Danish Medical Bulletin 40(1): 111-121
Siegl, P.K.; McNeill, J.H. 1980: Comparison of the alpha-adrenergic agonists, phenylephrine and methoxamine in rabbit papillary muscles Research Communications in Chemical Pathology and Pharmacology 30(2): 221-231
Wurch, T.; Okuda, J.; Pauwels, P.J. 2001: Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein Molecular Pharmacology 60(4): 666-673
Marlin, G.E.; Berend, N.; Harrison, A.C. 1979: Combined cholinergic antagonist and beta 2-adrenoceptor agonist bronchodilator therapy by inhalation Australian and New Zealand Journal of Medicine 9(5): 511-514
Gross, D.M.; Fisher, J.W. 1978: Effects of terbutaline, a synthetic beta adrenoceptor agonist, on in vivo erythropoietin production Archives Internationales de Pharmacodynamie et de Therapie 236(2): 192-201
Conway, J. 1980: The antihypertensive action of beta-adrenoceptor blocking agents Archives Internationales de Pharmacodynamie et de Therapie Suppl: 83-91
Kenny, D.; Pelc, L.R.; Brooks, H.L.; Kampine, J.P.; Schmeling, W.T.; Warltier, D.C. 1989: Alterations of alpha 1 and alpha 2 adrenoceptor-mediated pressor responses by halothane and isoflurane anesthesia Anesthesiology 71(2): 224-234